India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 24.08 42.49
Tata Stl 136.20 30.33
Ong Corp 256.00 95.64
I T C Lt 438.65 28.62
Ntpc Ltd 319.00 89.15
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Zydus Lifesciences Limited
Zydus Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532321NSE:ZYDUSLIFEBloomberg:CDH@INReuters:CADI.BO
Market Lot: 1Face Value: 1ISIN Demat: INE010B01027
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
10-Mar-2022       Zydus gets final nod from USFDA for Nitroglycerin Sublingual Tablets  IRIS
09-Mar-2022       Zydus Lifesciences arm executes asset purchase agreement with BridgeBio IRIS
23-Feb-2022       Cadila Healthcare gets final nod from USFDA for Dapagliflozin Tablets IRIS
02-Feb-2022       Zydus supplies first consignment of COVID-19 vaccine ZyCoV-D IRIS
13-Dec-2021       Zydus gets approval for Phase II Clinical study in patients with CAPS in Australia IRIS
22-Nov-2021       Cadila Healthcare gets final approval from USFDA for Decitabine Injection IRIS
12-Nov-2021       Cadila receives tentative approval from USFDA for Eluxadoline Tablets IRIS
21-Sep-2021       Cadila Healthcare arm inks pact with Integrace IRIS
20-Aug-2021       Cadila Healthcare partners with CHEMI of Italy IRIS
20-Aug-2021       Cadila Healthcare partners with CHEMI of Italy IRIS
13-Aug-2021       Cadila gets final USFDA nod for Mesalamine Extended-Release Capsules  IRIS
25-Jun-2021       Cadila receives USFDA nod for chemotherapy drug  IRIS
21-Jun-2021       Zydus and Bayer extend joint venture by three years  IRIS
02-Jun-2021       Zydus Cadila gets final nod from USFDA for Fluphenazine Hydrochloride Tablets  IRIS
28-May-2021       Zydus Cadila introduces IT enabled scratch code on product packs IRIS
26-May-2021       Zydus, TLC to market antifungal drug Liposomal Amphotericin B IRIS
12-May-2021       Cadila Healthcare enters into BTA with Zenex Animal Health IRIS
05-May-2021       Cadila Healthcare extends tenure of JV with Bayer IRIS
09-Apr-2021       Zydus Cadila gets USFDA approval for Ibrutinib Capsules IRIS
07-Apr-2021       Zydus seeks DCGI approval for a hepatitis drug to treat COVID-19 IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer